AN AUSTRALIAN man has said the decision to pay $100,000 to self-fund his own treatment was more stressful than being told he had cancer.
MRV Research
Oncolytic Virus Plus Ipilimumab Improves Responses in Advanced Melanoma
The combination of an oncolytic virus known as talimogene laherparepvec with ipilimumab yielded a significantly higher response rate than ipilimumab alone in a phase II study of patients with advanced melanoma.
National Skin Cancer Action Week 19-25 November 2018
Ahead of this year’s National Skin Cancer Action Week, MMP clinicians and researchers descended on Brisbane for a joint meeting of the 9th World Congress of Melanoma and 14th International Congress of the Society for Melanoma Research – the world’s largest congress on melanoma with over 1500 delegates from 53 countries.
Vote for Jessica Duarte, one of MMP’s awesome young scientists.
Summary of her project: Melanoma, known as Australia’s national cancer, is the deadliest type of skin cancer with the highest rates being reported in Australia and New Zealand (~60 cases per 100 000 individuals per year). Locally, melanoma is also the most commonly diagnosed cancer in young Australians aged between 15 and 39 years, making up 20% of all cancer cases and killing more of these individuals than any other single cancer.